Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
South London & Maudsley NHS Foundation Trust, London, UK.
Psychol Med. 2023 Sep;53(12):5385-5394. doi: 10.1017/S0033291722002343. Epub 2022 Aug 3.
(IAPT) is a primary care therapy service commissioned by England's National Health Service (NHS) for people with unipolar depression and anxiety-related disorders. Its scope does not extend to 'severe mental illness', including bipolar disorders (BD), but evidence suggests there is a high BD prevalence in ostensibly unipolar major depressive disorder (uMDD) samples. This study aimed to indicate the prevalence and characteristics of people with BD in a naturalistic cohort of IAPT patients.
371 participants were assessed before initiating therapy. Participants were categorised by indicated diagnoses: BD type-I (BD-I) or type-II (BD-II) as defined using a DSM diagnostic interview, bipolar spectrum (BSp, not meeting diagnostic criteria but exceeding BD screening thresholds), lifetime uMDD or other. Information about psychiatric history and co-morbidities was examined, along with symptoms before and after therapy.
368 patients provided sufficient data to enable classification. 10% of participants were grouped as having BD-I, 20% BD-II, 40% BSp, 25% uMDD and 5% other. BD and uMDD participants had similar demographic characteristics, but patients meeting criteria for BD-I/BD-II had more complex psychiatric presentations. All three 'bipolar' groups had particularly high rates of anxiety disorders. IAPT therapy receipt was comparable between groups, as was therapy response ( = 1.113, = 0.351).
Notwithstanding the possibility that bipolar diathesis was overestimated, findings illustrate a high prevalence of BD in groups of people notionally with uMDD or anxiety. As well as improving the detection of BD, further substantive investigation is required to establish whether individuals affected by BD should be eligible for primary care psychological intervention.
(IAPT)是英国国民保健制度(NHS)委托的初级保健治疗服务,用于治疗单相抑郁症和焦虑相关障碍患者。它的服务范围不包括“严重精神疾病”,包括双相情感障碍(BD),但有证据表明,在表面上单相重性抑郁障碍(uMDD)样本中,BD 的患病率很高。本研究旨在表明 IAPT 患者自然队列中 BD 患者的患病率和特征。
371 名参与者在开始治疗前接受了评估。根据指示性诊断对参与者进行分类:使用 DSM 诊断访谈定义的 I 型(BD-I)或 II 型(BD-II)双相情感障碍,双相谱(BSp,未达到诊断标准但超过 BD 筛查阈值),终生 uMDD 或其他。检查了精神病史和合并症信息,以及治疗前后的症状。
368 名患者提供了足够的数据进行分类。10%的参与者被归类为患有 BD-I,20%为 BD-II,40%为 BSp,25%为 uMDD,5%为其他。BD 和 uMDD 患者具有相似的人口统计学特征,但符合 BD-I/BD-II 标准的患者具有更复杂的精神表现。所有三个“双相”组的焦虑障碍发生率都特别高。各组接受 IAPT 治疗的比例相当,治疗反应也相当(=1.113,=0.351)。
尽管双相情感障碍的易感性可能被高估,但研究结果表明,在名义上患有 uMDD 或焦虑症的人群中,BD 的患病率很高。除了提高对 BD 的检测外,还需要进一步进行实质性研究,以确定是否应让受 BD 影响的个体有资格接受初级保健心理干预。